Structure-activity relationships of flavonoids and the induction of granulocytic- or monocytic-differentiation in HL60 human myeloid leukemia cells

被引:71
作者
Takahashi, T
Kobori, M
Shinmoto, H
Tsushida, T
机构
[1] Iwate Ind Res Inst, Morioka, Iwate 0200852, Japan
[2] Minist Agr Forestry & Fisheries, Natl Food Res Inst, Tsukuba, Ibaraki, Japan
关键词
flavonoids; differentiation; HL60 human leukemia cells; apigenin; genistein;
D O I
10.1271/bbb.62.2199
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The flavones apigenin and luteolin strongly inhibited the growth of HL60 cells and induced morphological differentiation into granulocytes. The flavonol quercetin inhibited the cell growth and induced a differentiation marker, i.e., NET reducing ability. However quercetin-treated cells were not morphologically differentiated into granulocytes. The chalcone phloretin weakly induced NET reducing ability and a marker of monocytic differentiation alpha-naphthyl butyrate esterase activity in the cells. Quercetin and phloretin appeared to induce the differentiation of HL60 cells into monocytes. The proportion of ol-naphthyl butyrate esterase-positive cells induced by genistein was less than that of the NET-positive cells. Some of the nuclei in genistein-treated HL60 cells morphologically changed. Genistein must have induced both granulocytic and monocytic differentiation of HL60 cells. The flavonols galangin and kaempferol, which had fewer hydroxyl group(s) in the B-ring than quercetin, and the flavanone naringenin inhibited the growth but did not induce the differentiation of HL60 cells.
引用
收藏
页码:2199 / 2204
页数:6
相关论文
共 35 条
[1]   Comparative effects of flavonoids on the growth, viability and metabolism of a colonic adenocarcinoma cell line (HT29 cells) [J].
Agullo, G ;
GametPayrastre, L ;
Fernandez, Y ;
Anciaux, N ;
Demigne, C ;
Remsey, C .
CANCER LETTERS, 1996, 105 (01) :61-70
[2]   Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: A comparison with tyrosine kinase and protein kinase C inhibition [J].
Agullo, G ;
GametPayrastre, L ;
Manenti, S ;
Viala, C ;
Remesy, C ;
Chap, H ;
Payrastre, B .
BIOCHEMICAL PHARMACOLOGY, 1997, 53 (11) :1649-1657
[3]  
AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
[4]   APOPTOSIS AND ITS MODULATION IN HUMAN PROMYELOCYTIC HL-60 CELLS TREATED WITH DNA TOPOISOMERASE-I AND TOPOISOMERASE-II INHIBITORS [J].
BERTRAND, R ;
SOLARY, E ;
JENKINS, J ;
POMMIER, Y .
EXPERIMENTAL CELL RESEARCH, 1993, 207 (02) :388-397
[5]   Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I [J].
Boege, F ;
Straub, T ;
Kehr, A ;
Boesenberg, C ;
Christiansen, K ;
Andersen, A ;
Jakob, F ;
Kohrle, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (04) :2262-2270
[6]  
CASTAIGNE S, 1990, BLOOD, V76, P1704
[7]   NORMAL FUNCTIONAL-CHARACTERISTICS OF CULTURED HUMAN PROMYELOCYTIC LEUKEMIA-CELLS (HL-60) AFTER INDUCTION OF DIFFERENTIATION BY DIMETHYLSULFOXIDE [J].
COLLINS, SJ ;
RUSCETTI, FW ;
GALLAGHER, RE ;
GALLO, RC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 149 (04) :969-974
[8]  
COLLINS SJ, 1987, BLOOD, V70, P1233
[9]  
CONSTANTINOU A, 1990, CANCER RES, V50, P2618
[10]   FLAVONOIDS AS DNA TOPOISOMERASE ANTAGONISTS AND POISONS - STRUCTURE-ACTIVITY-RELATIONSHIPS [J].
CONSTANTINOU, A ;
MEHTA, R ;
RUNYAN, C ;
RAO, K ;
VAUGHAN, A ;
MOON, R .
JOURNAL OF NATURAL PRODUCTS-LLOYDIA, 1995, 58 (02) :217-225